Evidence map›Paper›PMID 33479044›Full record

ArticleThorax2021

Validity and responsiveness of the Daily- and Clinical visit-PROactive Physical Activity in COPD (D-PPAC and C-PPAC) instruments.

Judith Garcia-Aymerich, Milo A Puhan, Solange Corriol-Rohou, Corina de Jong, Heleen Demeyer, Fabienne Dobbels, Damijan Erzen, Anja Frei, Elena Gimeno-Santos, Nicholas S Hopkinson and 10 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Thorax, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 3 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 3 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Physical activity measurements in individuals with interstitial lung disease: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2023
    Pooled it
  3. Pooled it
  4. Trial
  5. Communication About Sexuality (COSY) Encourages Physical Activity in COPD: A Randomised Trial.International journal of chronic obstructive pulmonary disease · 2025
    Trial
  6. Trial
  7. Lung volume reduction surgeryThe European respiratory journal · 2023
    Trial
  8. Trial
  9. Article
  10. Observational
  11. Observational
  12. Article
  13. Review
  14. Article
  15. Use of Ecological Momentary Assessment to Measure Dyspnea in COPD.International journal of chronic obstructive pulmonary disease · 2024
    Article
  16. Review
  17. Article
  18. Cultural adaptation and validation of the Brazilian Portuguese version of the PROactive Physical Activity in COPD-clinical visit instrument for individuals with COPD.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2023
    Article
  19. A cross-sectional survey on the effects of ambient temperature and humidity on health outcomes in individuals with chronic respiratory disease.Canadian journal of respiratory therapy : CJRT = Revue canadienne de la therapie respiratoire : RCTR · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 15 institutions in 15 countries.

Judith Garcia-AymerichISGlobal, Barcelona, Spain judith.garcia@isglobal.org.ORCID 0000-0002-7097-4586
Milo A PuhanEpidemiology, Biostatistics & Prevention Institute, University of Zurich, Zurich, Switzerland.
Solange Corriol-RohouAstraZeneca R&D, Paris, France.
Corina de JongGroningen Research Institute for Asthma and COPD (GRIAC), University of Groningen,University Medical Center Groningen (UMCG), Groningen, The Netherlands.
Heleen DemeyerDepartment of Respiratory Diseases, University Hospital Leuven, Leuven, Belgium.
Fabienne DobbelsAcademic Centre for Nursing and Midwifery, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.
Damijan ErzenGlobal Clinical Operations, Boehringer Ingelheim Pharma GmbH and Co. KG, Biberach, Germany.
Anja FreiEpidemiology, Biostatistics & Prevention Institute, University of Zurich, Zurich, Switzerland.
Elena Gimeno-SantosRespiratory Clinic Institute, Hospital Clinic of Barcelona, Barcelona, Spain.ORCID 0000-0001-5149-2015
Nicholas S HopkinsonNational Heart and Lung Institute, Imperial College London, London, UK.ORCID 0000-0003-3235-0454
Nathalie IvanoffAlmirall S A, Barcelona, Spain.
Niklas KarlssonAstraZeneca, BioPharmaceuticals Medical, Gothenburg, Sweden.
Zafeiris LouvarisDepartment of Rehabilitation Sciences, KU Leuven -University of Leuven, Leuven, Belgium.
Michael I PolkeyRoyal Brompton & Harefield NHS Foundation Trust, London, UK.
Roberto A RabinovichELEGI and COLT Laboratories, The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, UK.
Mario ScuriGlobal Pharmacovigilance, Chiesi Pharmaceutici, Parma, Italy.
Maggie TabbererGlaxoSmithKline, London, UK.
Ioannis VogiatzisFirst Department of Respiratory Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Thierry TroostersDepartment of Respiratory Diseases, University Hospital Leuven, Leuven, Belgium.
PROactive consortium
KU Leuven · BENational and Kapodistrian University of Athens · GRUniversity of Zurich · CHAlmirall (Spain) · ESAstraZeneca (France) · FRAstraZeneca (Italy) · ITBoehringer Ingelheim (Germany) · DEChiesi (Italy) · ITGlaxoSmithKline (United Kingdom) · GBHospital Clínic de Barcelona · ESLung Institute · USRoyal Brompton & Harefield NHS Foundation Trust · GBThe Queen's Medical Research Institute · GBUniversitat Pompeu Fabra · ESUniversity Medical Center Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Daily-PROactive and Clinical visit-PROactive Physical Activity (D-PPAC and C-PPAC) instruments in chronic obstructive pulmonary disease (COPD) combines questionnaire with activity monitor data to measure patients' experience of physical activity. Their amount, difficulty and total scores range from 0 (worst) to 100 (best) but require further psychometric evaluation.

objectiveTo test reliability, validity and responsiveness, and to define minimal important difference (MID), of the D-PPAC and C-PPAC instruments, in a large population of patients with stable COPD from diverse severities, settings and countries.

methodsWe used data from seven randomised controlled trials to evaluate D-PPAC and C-PPAC internal consistency and construct validity by sex, age groups, COPD severity, country and language as well as responsiveness to interventions, ability to detect change and MID.

resultsWe included 1324 patients (mean (SD) age 66 (8) years, forced expiratory volume in 1 s 55 (17)% predicted). Scores covered almost the full range from 0 to 100, showed strong internal consistency after stratification and correlated as a priori hypothesised with dyspnoea, health-related quality of life and exercise capacity. Difficulty scores improved after pharmacological treatment and pulmonary rehabilitation, while amount scores improved after behavioural physical activity interventions. All scores were responsive to changes in self-reported physical activity experience (both worsening and improvement) and to the occurrence of COPD exacerbations during follow-up. The MID was estimated to 6 for amount and difficulty scores and 4 for total score.

conclusionsThe D-PPAC and C-PPAC instruments are reliable and valid across diverse COPD populations and responsive to pharmacological and non-pharmacological interventions and changes in clinically relevant variables.

Indexed as

Quality of LifeExerciseExercise TherapyExercise ToleranceFollow-Up StudiesForced Expiratory VolumeHumansProspective StudiesPsychometricsPulmonary Disease, Chronic ObstructiveSurveys and QuestionnairesCOPD epidemiologyexercise

Identifiers

PMID33479044
PMCPMC7892393
OpenAlexW3125972857

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.